Health | Insurance Europe

Health systems should continue to be regulated at national level

EU member states are responsible for the organisation of their healthcare systems. Nevertheless, legislative developments at European level can have a significant direct or indirect impact on private health insurers with a significant direct or indirect impact on private health insurers, such as in their use of genetic information, for example.

There is continued scrutiny about the use of genetic information by health insurers in the EU, even though insurers generally do not use or ask for predictive genetic test results, except in very specific cases that are defined and regulated at national level.

Insurance Europe believes that it would be difficult for any EU-level regulation on the use of genetic information — or indeed of many other health-related issues — to capture the existing diversity in national markets.

Health claims


	Health claims paid, €bn	Growth rate, %
2008	74.8
2009	79.7	6.1
2010	83.8	3.8
2011	88.3	5.1
2012	85.3	-3.6
2013	93.1	9.4
2014	93.8	0.4
2015	99.9	5.4
2016	101.4	2.3
2017	103.5	3
Colour	#f78f1e	#000000
url	/node/4321	/node/4321

Candlestick

Hover over the bars for each data point, or click on a bar to see health claims by country data.

Notes:
Nominal €-values at current end-of-year exchange rates
Nominal %-growth at constant end-of-year exchange rates
Figures are for Domestic Market (business written on home territory by domestic companies, including subsidiaries + 3rd country branches), unless stated otherwise
For national specificities, please, see country breakdown chart
Size of the sample (as % of total premiums): 99.51%

Health premiums


Total	Health premiums, €bn	Growth rate, %
2008	97.2
2009	101.6	4.1
2010	108.4	5.1
2011	113.1	4.1
2012	115.7	2
2013	118.3	2.6
2014	120	1.1
2015	125.7	3.5
2016	128.2	2.9
2017	131.9	4
Colour	#f78f1e	#000000
url	/node/4231	/node/4231

Candlestick

Hover over the bars for each data point, or click on a bar to see health premiums by country data.

Notes:
Nominal €-values at current end-of-year exchange rates
Nominal %-growth at constant end-of-year exchange rates
Figures are for Domestic Market (business written on home territory by domestic companies, including subsidiaries + 3rd country branches), unless stated otherwise
For national specificities, please, see country breakdown chart
Size of the sample (as % of total premiums): 98%